Cannara Biotech Inc. (LOVFF) Stock Overview
Explore Cannara Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.
Cannara Biotech Inc. (LOVFF)
Key Financials
Key Financials
Market Cap
118.5M
P/E Ratio
15.88
EPS (TTM)
$0.08
ROE
0.09%
LOVFF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cannara Biotech Inc. (LOVFF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 38.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.88 and a market capitalization of 118.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.